Zenas BioPharma Inc. (ZBIO)

NASDAQ: ZBIO · Real-Time Price · USD

11.92

0.36 (3.11%)

At close: May 02, 2025, 3:59 PM

11.92

0.00%

After-hours: May 02, 2025, 04:20 PM EDT

Zenas BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q1 2023	Q4 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Mar 31, 2023	Dec 31, 2022
Cash & Equivalents	319.74M	360.04M	183.93M	37.15M	56.86M	72.31M	n/a	67.21M
Short-Term Investments	31.02M	26.76M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	12.86M	9.11M	10.65M	8.5M	7.36M	5.97M	-67.21M	4.33M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.16M	6.98M	4.67M	2.55M	2.95M	4.37M	n/a	1.24M
Total Current Assets	355.92M	393.78M	188.6M	39.7M	59.8M	76.68M	67.21M	68.44M
Property-Plant & Equipment	1.19M	545K	706K	847K	1.01M	1.15M	n/a	1.8M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.04M	9.65M	11.35M	9.35M	8.38M	7.12M	-67.21M	6.13M
Total Assets	369.97M	403.43M	199.95M	49.05M	68.18M	83.79M	n/a	74.58M
Account Payables	17.14M	15.08M	8.36M	8.83M	5.4M	2.28M	n/a	5.82M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	8.31M	6.19M	4.37M	3.72M	5.12M	4.12M	n/a	4.33M
Total Current Liabilities	57.29M	44M	39.11M	30.33M	23.26M	15.56M	n/a	25.97M
Long-Term Debt	n/a	n/a	n/a	20.99M	20.3M	20M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	449.61M	250.09M	250.09M	250.09M	-47.8M	240.09M
Total Long-Term Liabilities	218K	n/a	449.63M	271.21M	270.64M	270.47M	-47.8M	240.9M
Total Liabilities	57.51M	44M	488.73M	301.55M	293.9M	286.02M	-47.8M	266.87M
Total Debt	1M	384K	508K	21.64M	21.11M	20.96M	n/a	1.53M
Common Stock	4K	4K	n/a	1K	n/a	1K	n/a	n/a
Retained Earnings	-387.39M	-334.79M	-296.18M	-258.2M	-230.4M	-205.82M	n/a	-193.28M
Comprehensive Income	194K	54K	104K	74K	37K	124K	-192.29M	-41K
Shareholders Equity	312.46M	359.44M	-288.78M	-252.5M	-225.72M	-202.23M	47.8M	-192.29M
Total Investments	31.02M	26.76M	n/a	n/a	n/a	n/a	n/a	n/a